Urethritis laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
:3- Positive [[leukocyte esterase test]] on first-void urine or microscopic examination of sediment from a spun first-void urine demonstrating ≥10 [[WBC]] per high power field.<ref name="pmid17331273">{{cite journal |vauthors=Horner PJ, Taylor-Robinson D |title=Is there a role for leucocyte esterase testing in non-invasive screening using nucleic acid amplification tests of asymptomatic men? |journal=Int J STD AIDS |volume=18 |issue=2 |pages=73–4 |year=2007 |pmid=17331273 |doi=10.1258/095646207779949718 |url=}}</ref> | :3- Positive [[leukocyte esterase test]] on first-void urine or microscopic examination of sediment from a spun first-void urine demonstrating ≥10 [[WBC]] per high power field.<ref name="pmid17331273">{{cite journal |vauthors=Horner PJ, Taylor-Robinson D |title=Is there a role for leucocyte esterase testing in non-invasive screening using nucleic acid amplification tests of asymptomatic men? |journal=Int J STD AIDS |volume=18 |issue=2 |pages=73–4 |year=2007 |pmid=17331273 |doi=10.1258/095646207779949718 |url=}}</ref> | ||
Once the diagnosis based on any of the above mentioned methods is confirmed, further testing to establish the etiology by nucleic acid amplification tests (NAATs) is recommended. | Once the diagnosis based on any of the above mentioned methods is confirmed, further testing to establish the etiology by nucleic acid amplification tests (NAATs) is recommended.<ref name="pmid26042815">{{cite journal |vauthors=Workowski KA, Bolan GA |title=Sexually transmitted diseases treatment guidelines, 2015 |journal=MMWR Recomm Rep |volume=64 |issue=RR-03 |pages=1–137 |year=2015 |pmid=26042815 |doi= |url=}}</ref> | ||
===Gram Stain=== | ===Gram Stain=== | ||
Revision as of 18:25, 3 October 2016
|
Urethritis Microchapters | |
|
Diagnosis | |
|
Treatment | |
|
Case Studies | |
|
Urethritis laboratory findings On the Web | |
|
American Roentgen Ray Society Images of Urethritis laboratory findings | |
|
Risk calculators and risk factors for Urethritis laboratory findings | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
Laboratory Findings
Urethritis is considered on the basis of any of the following:[1][2][3]
- 1- Mucoid, mucopurulent, or purulent discharge on examination.
- 2- Gram stain of urethral secretions demonstrating ≥2 WBC per field
- 3- Positive leukocyte esterase test on first-void urine or microscopic examination of sediment from a spun first-void urine demonstrating ≥10 WBC per high power field.[4]
Once the diagnosis based on any of the above mentioned methods is confirmed, further testing to establish the etiology by nucleic acid amplification tests (NAATs) is recommended.[3]
Gram Stain
- The presence of PMNs without any visible organisms is consistent with nongonococcal urethritis.[1]
- Presumed gonococcal infection is established by documenting the presence of WBC containing intracellular purple diplococci in gram stain.[5]
References
- ↑ 1.0 1.1 Jacobs NF, Kraus SJ (1975). "Gonococcal and nongonococcal urethritis in men. Clinical and laboratory differentiation". Ann. Intern. Med. 82 (1): 7–12. PMID 67816.
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 9781455748013.
- ↑ 3.0 3.1 Workowski KA, Bolan GA (2015). "Sexually transmitted diseases treatment guidelines, 2015". MMWR Recomm Rep. 64 (RR-03): 1–137. PMID 26042815.
- ↑ Horner PJ, Taylor-Robinson D (2007). "Is there a role for leucocyte esterase testing in non-invasive screening using nucleic acid amplification tests of asymptomatic men?". Int J STD AIDS. 18 (2): 73–4. doi:10.1258/095646207779949718. PMID 17331273.
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 9781455748013.